Literature DB >> 6574124

Prostaglandin--E2 levels in the saliva of common migrainous women.

J Vardi, S Flechter, A Alguati, I Regev, D Ayalon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6574124     DOI： 10.1111/j.1526-4610.1983.hed2302059.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  4 in total

1.  Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones.

Authors:  D W Jenkins; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Advances in drug development for acute migraine.

Authors:  Ryan J Cady; Candace L Shade; Roger K Cady
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

3.  BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.

Authors:  K A Maubach; R J Davis; D E Clark; G Fenton; P M Lockey; K L Clark; A W Oxford; R M Hagan; C Routledge; R A Coleman
Journal:  Br J Pharmacol       Date:  2009-01-19       Impact factor: 8.739

4.  Monocyte chemotactic and phagocytic responses in migraine and tension-type headache patients.

Authors:  V Gallai; P Sarchielli; A Trequattrini; M Paciaroni
Journal:  Ital J Neurol Sci       Date:  1993-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.